Page last updated: 2024-08-23

silybin and Anaplastic Large-Cell Lymphoma

silybin has been researched along with Anaplastic Large-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lai, R; Lavasanifar, A; Molavi, O; Samadi, N; Wu, C	1

Other Studies

1 other study(ies) available for silybin and Anaplastic Large-Cell Lymphoma

Article	Year
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma. Leukemia & lymphoma, 2016, Volume: 57, Issue:5 Topics: Anaplastic Lymphoma Kinase; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Phosphorylation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Signal Transduction; Silybin; Silymarin; SOXB1 Transcription Factors	2016

Article

Year

Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.

Leukemia & lymphoma, 2016, Volume: 57, Issue:5

Topics: Anaplastic Lymphoma Kinase; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Phosphorylation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Signal Transduction; Silybin; Silymarin; SOXB1 Transcription Factors

2016